20
Mylan Laboratories Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is BROENAC SODIUM, with a corresponding US DMF Number 25315.
Remarkably, this DMF maintains an Active status since its submission on November 15, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 23, 2014, and payment made on September 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II